Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

11/5/19 dc mupirocin oint shortage
November 5, 2019

From: "David Collette" <david.collette@hhsys.org>
To: "grp allpharm" <grp_allpharm@hhsys.org>
Sent: Tuesday, November 5, 2019 3:33:38 PM
Subject: mupirocin oint shortage

We are unable to obtain mupirocin ointment at this time. We need to preserve our current supply for documented MRSA wound infections, thus we need to be using the alternatives listed in # 1 and 2 below. Richard is looking through previous P&T minutes when we substituted povidone iodine for mupirocin in a previous shortage, so this MAY be an automatic switch. The polysporin substitution for EMPIRIC topical use may have to go through P&T to make it automatic (we can do so quickly), but for now you would need to contact the physician to switch. This would allow us to reserve mupirocin for documented MRSA wound infections. Please begin efforts to conserve mupirocin immediately. More info to follow tomorrow.






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved